Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05255484 |
| Title | Study of LM-108 as a Single Agent or in Combination With Pembrolizumab in Subjects With Advanced Solid Tumours |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | LaNova Medicines Limited |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Ocala Oncology Center | Ocala | Florida | 34474 | United States | Details | |
| Indiana University Melvin and Bren Simon Comprehensive Cancer Center | Indianapolis | Indiana | 46202 | United States | Details | |
| Gabrail Cancer and Research Center | Canton | Ohio | 44718 | United States | Details | |
| The Christ Hospital | Cincinnati | Ohio | 45219 | United States | Details | |
| University of Oklahoma | Norman | Oklahoma | 73104 | United States | Details | |
| Mary Crowley Cancer Research | Dallas | Texas | 75230 | United States | Details |